...(audio in progress) back everyone next, we have Jaguar Health. It trades on the Nasdaq under the symbol JAGX. It's a commercial-stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, and bowel incontinence. Today, we'll be speaking with Lisa Conte, Founder, CEO, President, and Director. Lisa is the founder of Jaguar Health. And so happy to have you back, Lisa. I want to also mention Mytesi, the company's FDA-approved drug, indicated for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on anti-retroviral therapy. It's first-in-class plant-based anti-secretory agent and the first oral drug approved under FDA botanical guidance. Now Ms. Conti has pioneered plant-based prescription medicine investigation and...
